Schuetze KB[au] - Search Results

Year	Number of Results
2013	1
2014	4
2015	1
2016	1
2017	1
2019	2
2023	0

1

The potential of targeting epigenetic regulators for the treatment of fibrotic cardiac diseases.

Schuetze KB, Koch KA, McKinsey TA. Schuetze KB, et al. Future Med Chem. 2016 Sep;8(13):1533-6. doi: 10.4155/fmc-2016-0144. Epub 2016 Aug 24. Future Med Chem. 2016. PMID: 27556930 Free PMC article. No abstract available.

2

Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.

Schuetze KB, McKinsey TA, Long CS. Schuetze KB, et al. J Mol Cell Cardiol. 2014 May;70:100-7. doi: 10.1016/j.yjmcc.2014.02.015. Epub 2014 Mar 11. J Mol Cell Cardiol. 2014. PMID: 24631770 Free PMC article. Review.

3

Transcatheter aortic valve replacements alter circulating serum factors to mediate myofibroblast deactivation.

Aguado BA, Schuetze KB, Grim JC, Walker CJ, Cox AC, Ceccato TL, Tan AC, Sucharov CC, Leinwand LA, Taylor MRG, McKinsey TA, Anseth KS. Aguado BA, et al. Among authors: schuetze kb. Sci Transl Med. 2019 Sep 11;11(509):eaav3233. doi: 10.1126/scitranslmed.aav3233. Sci Transl Med. 2019. PMID: 31511425 Free PMC article.

4

Contemporary Use of Embolic Protection Devices During Saphenous Vein Graft Intervention.

Valle JA, Glorioso TJ, Schuetze KB, Grunwald GK, Armstrong EJ, Waldo SW. Valle JA, et al. Among authors: schuetze kb. Circ Cardiovasc Interv. 2019 May;12(5):e007636. doi: 10.1161/CIRCINTERVENTIONS.118.007636. Circ Cardiovasc Interv. 2019. PMID: 31014092

5

Overlapping and Divergent Actions of Structurally Distinct Histone Deacetylase Inhibitors in Cardiac Fibroblasts.

Schuetze KB, Stratton MS, Blakeslee WW, Wempe MF, Wagner FF, Holson EB, Kuo YM, Andrews AJ, Gilbert TM, Hooker JM, McKinsey TA. Schuetze KB, et al. J Pharmacol Exp Ther. 2017 Apr;361(1):140-150. doi: 10.1124/jpet.116.237701. Epub 2017 Feb 7. J Pharmacol Exp Ther. 2017. PMID: 28174211 Free PMC article.

6

Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes.

Williams SM, Golden-Mason L, Ferguson BS, Schuetze KB, Cavasin MA, Demos-Davies K, Yeager ME, Stenmark KR, McKinsey TA. Williams SM, et al. Among authors: schuetze kb. J Mol Cell Cardiol. 2014 Feb;67:112-25. doi: 10.1016/j.yjmcc.2013.12.013. Epub 2013 Dec 26. J Mol Cell Cardiol. 2014. PMID: 24374140 Free PMC article.

7

HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling.

Demos-Davies KM, Ferguson BS, Cavasin MA, Mahaffey JH, Williams SM, Spiltoir JI, Schuetze KB, Horn TR, Chen B, Ferrara C, Scellini B, Piroddi N, Tesi C, Poggesi C, Jeong MY, McKinsey TA. Demos-Davies KM, et al. Among authors: schuetze kb. Am J Physiol Heart Circ Physiol. 2014 Jul 15;307(2):H252-8. doi: 10.1152/ajpheart.00149.2014. Epub 2014 May 23. Am J Physiol Heart Circ Physiol. 2014. PMID: 24858848 Free PMC article.

8

TNAP: a new player in cardiac fibrosis? Focus on "Tissue-nonspecific alkaline phosphatase as a target of sFRP2 in cardiac fibroblasts".

Schuetze KB, McKinsey TA. Schuetze KB, et al. Am J Physiol Cell Physiol. 2015 Aug 1;309(3):C137-8. doi: 10.1152/ajpcell.00167.2015. Epub 2015 Jun 24. Am J Physiol Cell Physiol. 2015. PMID: 26108666 Free PMC article. No abstract available.

9

Reversal of severe angioproliferative pulmonary arterial hypertension and right ventricular hypertrophy by combined phosphodiesterase-5 and endothelin receptor inhibition.

Cavasin MA, Demos-Davies KM, Schuetze KB, Blakeslee WW, Stratton MS, Tuder RM, McKinsey TA. Cavasin MA, et al. Among authors: schuetze kb. J Transl Med. 2014 Nov 26;12:314. doi: 10.1186/s12967-014-0314-y. J Transl Med. 2014. PMID: 25425003 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results